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Introduction
We are conducting a study regarding the underlying genetic and endocrine mechanisms for Osteoporosis and Related Bone Disease such as skeletal mineralization defects related to chronic kidney failure. Osteoporosis is a significant health problem. It is estimated that 44 million Americans, nearly 70% of which are women, are affected by this disease. It is of particular concern to the Veteran's Administration since women are now the fastest growing segment of veterans. Our work and the work of others have revealed much about the complex physiology of bone development and maintenance including the endocrine regulation of mineral homeostasis that is absolutely necessary for skeletal health. Hormonal factors from bone, kidneys and parathyroid glands form an interactive network to maintain a tight balance of minerals in the body. Our proposal is to develop a better understanding of how one protein in particular, Klotho, specifically contributes to bone mineralization defects. We hypothesize that tissue-specific reduced expression of Klotho is responsible for the bone mineralization defects present in patients with osteoporosis and/or chronic kidney disease. To investigate this hypothesis we have experimentally deleted Klotho expression in parathyroid glands, kidneys, and bone independently to determine 1) how each organ contributes to the disease processes and 2) the relative contribution of each organ to the mineralization defects. We are using our transgenic mouse that utilizes Crelox technology to selectively ablate Klotho in each organ and analyze the effects to support our hypothesis. 
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Accomplishments

Major Goals and Tasks
To test our hypothesis and attain our overall aim of delineating the tissue-specific role of Klotho in osteoporosis, CKD-MBD and other bone pathology, we proposed the following specific aims. Each aim is designed to study a specific tissue using floxed Klotho (Klotho fl/fl ) mice crossed with a mouse line carrying the Cre recombinase gene driven by a tissue specific promoter. Mice from these crosses have Klotho ablated from the target tissue by Cre-LoxP recombination.
SA1: Parathyroid gland-specific deletion of Klotho: Klotho has been reported to mediate the suppression of PTH by FGF23. In addition, Klotho has been shown to recruit the Na+,K+-ATPase to the cell surface upon changes in calcium concentrations in the parathyroid gland. It has been suggested that a decrease in Klotho expression in the parathyroid gland is responsible for the induction of secondary hyperparathyroidism due to a resistance to FGF23 suppression of PTH transcription/secretion in CKD-MBD. Specific deletion of Klotho from the parathyroid gland is therefore an important prerequisite to obtain novel information about Klotho's organspecific function in mineral ion homeostasis. Klotho fl/fl mice will be crossed with PTHcre mice to generate mice with Klotho specifically ablated in the parathyroid glands. We will compare PTHcre;Klotho fl/fl and their control Klotho fl/fl littermates under normal conditions and then under disease conditions by feeding them an Adenine diet or optionally by 5/6 nephrectomy to induce CKD. The results obtained from this study will provide evidence whether Klotho signaling in the parathyroid glands has a critical role in bone mineral defects.
SA2: Kidney-specific deletion of Klotho: Renal expression of Klotho is important for normal mineral ion homeostasis. To examine the consequence of loss of renal Klotho function from the entire kidney, Klotho fl/fl mice will be crossed with Six2cre transgenic mice; Jax #009606-Six2-EGFP/cre1Amc/J. Six2-expressing cap mesenchyme represents a multipotent nephron progenitor population; therefore deletion of Klotho is anticipated throughout the kidney. Moreover, we plan to refine our data to determine whether Klotho expression in proximal or distal tubules is more critical for CKD-MBD. We have recently demonstrated that Klotho is expressed not only in distal tubules but also in proximal tubules of the kidney. This is an important finding because prior to these data it was unclear how Fgf23 could downregulate the sodium phosphate co-transporters (NaPi2a, NaPi2c) and inhibit expression of the 1α(OH)ase in proximal tubules if Klotho was expressed only in distal tubules. We will investigate the importance of Klotho functions in both tubules by separately ablating Klotho from each cell type. In order to identify Klotho's potential role in proximal tubules to regulate phosphate and vitamin D homeostasis, Klotho fl/fl mice will be crossed with kidney androgen-regulated protein (KAP)cre transgenic mice. To investigate Klotho's function in distal tubules where it has been reported to induce renal calcium re-absorption by its actions on TRPV5 Klotho fl/fl mice were crossed with mouse cadherin 16 (Ksp 1.3 kb);cre mice (article published by JASN; see preliminary data). Induction of CKD in this mouse strain will determine whether renal Klotho is involved in the progression of bone mineralization defects and to what extent this involvement derives from the proximal versus distal tubules. We will compare kidney-specific cre;Klotho fl/fl and their control Klotho fl/fl littermates under normal conditions and then under disease conditions by feeding them an Adenine diet or optionally by 5/6 nephrectomy to induce CKD. The results obtained from this study will provide evidence whether Klotho signaling in the kidney has a critical role.
SA3: Bone-specific deletion of Klotho: We and others have recently found that Klotho is expressed at low levels in osteoblasts and that Klotho -/-mice exhibit a severe mineralization defect in vivo and in vitro. Most importantly, we have recently discovered that Klotho and PTH function independently of FGF23 to affect bone mineralization. To determine the mechanism that underlies this previously unknown function of Klotho in bone mineralization, we will cross Klotho fl/fl mice with various cre transgenic mice (Prx1cre, Col 1(α1)cre, and DMP1cre) to generate mice with Klotho specifically ablated in the bone. The result obtained from this study will elucidate whether loss of Klotho expression from bone contributes to the mineralization defect observed in osteoporosis, CKD-MBD and other diseases. We will compare bone-specific cre;Klotho fl/fl and their control Klotho fl/fl littermates under normal conditions and then under disease conditions by feeding them an Adenine diet or optionally by 5/6 nephrectomy to induce CKD. The results obtained from this study will provide evidence whether Klotho signaling in the bone has a critical role.
The following set of tasks will be performed for each of the transgenic mouse models listed. Note: the tasks are not completely linear and a subsequent task may begin prior to the end of the previous task. Phosphorus and 0.6% Calcium) with or without addition of adenine for a period of 4 weeks. The mice will start on the diet at weaning (3 weeks old).
• 5/6 nephrectomy: This procedure will only be performed if the Adenine Diet is not sufficient to induce CKD. We do not expect this since we have already confirmed that the protocol we have established for the Adenine Diet is effective. Nevertheless, as backup plan we would remove 2/3 of the first kidney at between 9-12 weeks of age. The second kidney would be completely removed one week later.
• All Mice will be monitored for adverse side-effects. 
Accomplishments
The results of our work for the previous period are summarized here, organized by specific mouse line. Specific target dates were not given in the SOW (see above). We report the percentage of work completed per mouse line based on the task times listed above. Aim 2 -KAPcre;Klotho fl/fl Mice We first re-confirmed our previous observation about the renal expression pattern of Klotho using immunohistochemistry. Klotho staining was detected in the renal cortex, but not in the medulla, of wild-type mice ( Figure 1A , left panel). In the cortex, distal tubules had a strong positive staining whereas in proximal tubules the staining was substantially weaker ( Figure 1A , right panel). We then confirmed the expression of Klotho mRNA using RNAScope, a novel method for in situ hybridization. Klotho RNA was predominately expressed in the distal tubules, with weaker but positive expression in proximal tubules ( Figure 1B ), consistent with the immunohistochemistry results. 
Characterization of Kap-KL mice
We investigated the importance of Klotho in proximal tubules by generating mice expressing Cre recombinase under the Kap promoter. AS stated in the last progress report, this was the best characterized proximal tubularspecific Cre strain available through public mice repositories. Cre expression in these mice has previously been shown to be restricted to the proximal tubules. To analyze the recombination specificity and efficiency of this line, mice were crossed with a tdTomato reporter strain. Figure 2A ) and survived as well as wild type littermates. First, we confirmed the deletion of Klotho from proximal tubules using immunohistochemistry ( Figure 2B ). We also evaluated isolated kidney proximal tubular cell homogenates and observed that Klotho mRNA expression was reduced by 66% (p=0.02, n=6) ( Figure 2C ) and Klotho protein expression was reduced by 52% (p=0.02, n=6) ( Figure 2D ). Next, we evaluated the expression of key renal genes by quantitative PCR (qPCR). Transcript levels of Npt2a were significantly increased in Kap-KL mice, whereas Npt2c expression levels were unchanged. Both Cyp27b1 and Cyp24a1 were significantly increased in Kap-KL mice (n=4-6)( Figure 2E ). Western blot analysis revealed significantly 6 increased Npt2a expression at the brush border membrane (BBM) in Kap-KL mice compared with Kap-WT mice (p=0.003, n=3) ( Figure 2F ). 
Kap-KL mice on high phosphate challenge
We originally planned to challenge this mouse strain with induced CKD in order to determine whether renal Klotho is involved in the progression of bone mineralization defects and to what extent this involvement derives from the proximal versus distal tubules. However as demonstrated in the last progress report, under normal conditions, there was no significant change in urine and serum levels of calcium and phosphate, nor in their regulatory factors (FGF23 and 1,25(OH) 2 D), except that serum PTH concentration significantly increases in KAP-KL mice. It was decided that both the adenine-induced CKD model and 5/6 Nephrectomy model were too severe to detect the milder role of Klotho in proximal tubules. Therefore, we focused on phosphate handling, which is assumed to be a key role of Klotho in proximal tubules and put further stress on renal phosphate handling. Both Kap-KL and Kap-WT mice were challenged with high phosphate (HP) in the drinking water for 8 weeks. Serum calcium and phosphate levels remained unchanged in both Kap-KL and Kap-WT (n=3-5) ( Figure 3A) . Importantly, Kap-WT mice substantially increased their urinary phosphate excretion after HP loading, however urinary phosphate excretion in Kap-KL mice on HP remained unchanged (n=5) ( Figure 3B ). This effect was not due to decreased renal function as serum creatinine and BUN were similar between groups (ns, n=3-5) ( Figure 3C ). Serum Fgf23 were significantly increased in both Kap-KL and Kap-WT mice on HP whereas 1,25(OH) 2 D levels were significantly increased only in Kap-KL on HP. PTH levels increased significantly in Kap-WT mice on HP when compared to unchallenged mice, whereas no changes were noted in Kap-KL mice ( Figure 3D ). Other proximal tubular-specific Cre strains We generated and tested additional mouse models to verify our observations in KAP Cre mice. We demonstrate that proximal tubular Klotho is important for renal phosphate reabsorption and that deletion of proximal tubular Klotho leads to hypophosphaturia. There is a definite, but limited, role for Klotho in renal proximal tubules. Deletion of Klotho from either distal or proximal tubules alone results in only minor changes in mineral homeostasis, suggesting an integrated and intricate cooperation between these two expression loci. The interplay between proximal and distal tubule is controlling mineral metabolism. Moreover, our data also suggest that Klotho expressed in the proximal tubules protects phosphate induced proximal tubular damage. The data of this Aim were submitted to Kidney International for publication and the manuscript is currently under revision and will be resubmitted during the next year.
Aim 3 -Prx1cre;Klotho fl/fl Mice This aim is to investigate how bone-specific changes in Klotho expression affect mineral ion homeostasis and the progression of bone mineralization defects in chronic kidney disease. For this purpose, floxed Klotho mice were crossed with mice expressing Cre recombinase under the control of the Prx1 promoter to create a mouse in which Klotho is deleted in early limb mesenchyme. We have continued to analyze the phenotype of control and mutant mice during the past year and are now ready to submit the data for publication. We have examined the phenotype of Klotho fl/fl and Prx1cre;Klotho fl/fl mice at 6 weeks of age and at 16 weeks of age after challenge with control and Adenine diet or sham and 5/6 NTX to induce renal failure. The data are shown below.
6-week old mice -In the previous report we noted that mice have lower BV/TV and connectivity.
Histomorphometric examinations of male femurs stained with toluene blue showed no statistically significant differences in trabecular bone volume or connectivity between groups for the selected region of interest. However, there was a trend, similar to findings from µCT, that Prx1cre;Klotho fl/fl mice have less trabecular bone volume and trabecular thickness in the distal femur than Klotho fl/fl mice. Increased bone resorption may exacerbate the loss of trabecular bone volume and connectivity of Prx1cre;Klotho fl/fl mice, so we assessed osteoclast number and activity by histomorphomtry, qRT-PCR and serum biochemistry analyses. TRAP staining of decalcified methylmethacrylate femur sections showed normal osteoclast number and surface in Prx1cre;Klotho fl/fl mouse femora compared to those in Klotho fl/fl mice. Gene expression analyses revealed that there are no significant differences in RANK mRNA expression between groups. However, biochemical measures of collagen breakdown revealed that Prx1cre;Klotho fl/fl mice have markedly reduced amounts of type I collagen fragments (CTX) in circulation compared to Klotho fl/fl mice. Since collagen breakdown is a measure of bone resorption these findings revealed that despite no changes in osteoclast number or activity Prx1cre; Klotho fl/fl mice have reduced bone resorption. It is well documented that osteoblasts regulate osteoclastogenesis through the production of cytokines, including the pro-osteoclastogenic factor RANKL and the antiosteoclastogenic decoy receptor OPG. We therefore measured the expression of RANKL and OPG in limbs of Klotho fl/fl and Prx1cre;Klotho fl/fl mice using qRT-PCR. The RANKL/OPG ratio is a key determinant of the extent of osteoclastogenesis. The ratio of RANKL to OPG expression in long bones of Prx1-Cre; Klotho fl/fl mice was reduced by <50%, suggesting that diminished osteoclast function results at least in part from aberrant osteoblast signaling. Histomorphometric analyses of male femurs revealed that there were no significant differences in osteoblast number or surface between groups. However, the expression of several osteoblast transcripts including Runx2, Col1α1, Osx, OC and ALP were significantly increased in Prx1cre; Klotho fl/fl femurs. mice. Moreover, the expression level of Glant3 mRNA in bone was unaffected. These together suggest that conditional deletion of mKlotho does not affect FGF23 degradation. Thus our data provide support for the hypothesis that, in the absence of mKlotho, bone cells become resistant to uremia induced increases in FGF23 transcription (Figure 6 ). From published studies we know that both FGF23 and PTH act on the kidney independently to stimulate phosphate wasting by decreasing the expression of the sodium-dependent phosphate co-transporters so we examined NaPi2a and NaPi2c expression. RT-PCR analyses of genomic DNA extracted from kidneys showed that adenine fed mice have suppressed expression of renal genes including Klotho, FGFR1, PTHR1, NaPi2a and NaPi2c, which is consistent with previous reports showing that adenine exposure induces severe renal destruction (Jia et al. BMC Nephrol. 2013. 14:116) . In rodents, NaPi2a is the major renal isoform responsible for the reabsorption of approximately 70% of filtered phosphate [18, 19] so we isolated renal BBMV to measure NaPi2a protein expression and could show that adenine fed mice had significantly less NaPi2a protein in the BBMV than control fed mice, and significantly higher urinary phosphate excretion (Figure 7) . In comparing across genotypes, adenine fed Prx1cre; Klotho fl/fl mice had less pronounced reductions in BBMV NaPi2a protein expression and lower urinary phosphate excretion than uremic Klotho fl/fl mice. In the kidney, where Klotho is most abundantly expressed, FGF23 binds to the Klotho-FGFR1 complex to lower 1,25(OH) 2 D 3 levels by inhibiting renal 1α-hydroxylase (Cyp27b1) and stimulating renal 24-hydroxyalase (Cyp24) production. At the same time, PTH increases 1,25(OH) 2 D levels by stimulating renal 1α-hydroxylase (Cyp27b1) production. As shown in our study, adenine fed Klotho fl/fl mice did not show significant changes in renal 1αOHase or 24OHase expression and had normal serum calcitriol and calcium concentrations. On the contrary, uremic Prx1cre;Klotho fl/fl mice had significantly higher renal 1αOHase expression and serum 1,25(OH) 2 D levels than all other treatment groups with no significant changes in 24OHase expression. Serum 1,25(OH) 2 D levels increase intestinal calcium absorption and suppress PTH secretion, which is in part why uremic Prx1cre;Klotho fl/fl mice were found to be hypercalcemic and have significantly lower serum PTH levels than uremic Klotho fl/fl mice (Figure 8 ). 
Findings confirmed in a second model of renal failure
We validated these results in 5/6 NTX mice. All NTX mice had significantly higher urea concentrations than sham-operated mice, confirming the induction of renal failure. There were no significant differences in serum phosphate levels between groups but, as expected, limbs of 5/6 NTX Klotho fl/fl mice had significantly higher FGF23 mRNA expression than those of sham-operated Klotho fl/fl mice. Limbs of 5/6 NTX Prx1cre;Klotho fl/fl mice, like those treated with adenine, were resistant to uremia induced increases in FGF23 mRNA transcription. As a result, serum iFGF23 levels of Klotho fl/fl mice rose from 168.0±8.4 to 902±316.6 after nephrectomy, while those of Prx1cre;Klotho fl/fl mice rose modestly from 149 ± 23.9 to 378.2 ± 43.8. All 5/6 NTX mice had significantly higher serum PTH and 1,25(OH) 2 D levels than sham-operated mice, which is consistent with progressive secondary HPT and altered mineral homeostasis. Serum calcium levels of Prx1cre;Klotho fl/fl mice increased significantly after nephrectomy but remained in the normal range, while there were no such increases observed in Klotho fl/fl mice ( Figure 9 ). 
Effects of limb bud-specific Klotho inactiovation on bone
Serum PINP and CTX analyses revealed that all uremic mice have increased bone turnover with no significant differences between uremic Klotho fl/fl and Prx1cre;Klotho fl/fl mice. As previously shown (Ferrari et al. BMC nephrology, 2014 . 15:69), adenine fed mice had higher serum PINP and CTX levels than 5/6 NTX mice, suggesting that adenine exposure induces a more severe form of metabolic bone disease. For this reason we used bones of adenine fed mice to characterize how conditional deletion of Klotho affects bone physiology. We show by high-resolution peripheral quantitative computer tomography (pQCT) that adenine fed mice have significantly lower bone mineral density (BMD) and cortical thickness than control fed mice, with greater losses observed in the conditional knockout model. It is well documented that PTH is catabolic in cortical bone and anabolic in trabecular bone, so it is no surprise that adenine fed mice with decreased amount of cortical bone had more trabecular bone than control fed mice. Specifically, the renal osteodystrophy associated with CKD-MBD and secondary hyperparathyroidism manifested in uremic Klotho fl/fl mice as significantly higher trabecular bone volume (BV/TV), trabecular thickness (Tb.Th.) and trabecular connectivity (higher Tb.N, lower Tb.Sp) compared with that of healthy controls, while no such effect was observed in uremic Prx1cre;Klotho fl/fl mice. As a result, trabecular bone volume, trabecular thickness and trabecular connectivity in distal femurs and lumbar vertebrae of uremic Prx1cre;Klotho fl/fl mice were not significantly different from those of healthy controls. Analyses of dynamic histomorphometric parameters revealed that both uremic Klotho fl/fl and Prx1cre;Klotho fl/fl mice have higher bone formation rate (BFR) and mineral apposition rate (MAR) in the distal femurs and lumbar vertebrae than their respective controls with no significant changes in the amount of mineralized surface. There were no differences in osteoid volume, osteoid thickness, osteoblast surface or osteocyte number between groups at the femur or the lumbar vertebrae. The osteoclast number and surface were significantly higher in the distal femurs, but not lumbar spines, of Prx1cre;Klotho fl/fl mice in response to uremia. This would suggest that conditional deletion of Klotho affects osteoclastogenesis.
We are planning to submit this manuscript shortly for publication and hope that this aim will then be completed.
Aim 3 -Dmp1cre;Klotho fl/fl Mice Recent experimental data have shown that Klotho is expressed at low levels in osteocytes, but the specific role of Klotho in osteocytes remains unknown. Klotho that is expressed in osteocytes may affect skeletal mineralization and systemic mineral homeostasis. We generated mice with Klotho specifically ablated in osteocytes by crossing Klotho fl/fl mice with DMP1cre mice to study this possibility. Moreover, emerging data suggest that expressions of Klotho in the kidney and the parathyroid gland are decreased in renal failure and this down-regulation plays an important role in the pathogenesis of CKD-MBD. Thus, we challenged these mutant mice by performing 5/6 nephrectomy in order to determine the potential role of osteocyte expressed Klotho in disease progression.
First, we confirmed Dmp1-Cre expression in bone by crossing DMP1cre mice with tdTomato fl/fl reporter mice (Figure 10 ). We also found Dmp1-Cre-mediated expression of tdTomato in the brain, muscle, intestine, and renal collecting duct, but no evidence for the expression of tdTomato in other Klotho-expressing tissues, including the renal proximal and distal tubules and parathyroid gland (data not shown). Consistent with these observations, there were marked reductions (~70%) in Klotho transcripts in the bone (Figure 10 ) but no changes in expression in the kidney or parathyroid glands. mice had increased bone volume/total volume (BV/TV), together with increased bone formation and serum levels of bone formation marker PINP at 5 weeks of age (Figure 11 ). We next challenged the mice by inducing renal failure by 5/6 nephrectomy with or without highphosphate diet. The surgical procedure was performed in 5 week-old mice following a twostep surgical procedure. Briefly, the right kidney was exposed, decapsulated, and two-thirds of the kidney was resected. After a 1-week recovery period, a left total nephrectomy was performed. After two weeks, BUN was quadrupled and serum creatinine was increased by 50% in nephrectomized mice (data not shown), confirming renal failure. For 5/6 nephrectomy plus highphosphate diet group, high-phosphate diet (containing 1.2% phosphate) was started 1 week after the second surgery. Other groups (sham surgery group and 5/6 nephrectomy group) continued to receive regular diet that contains 0.6% phosphate.
After 5/6 nephrectomy, there were significant increases in serum calcium, PTH, 1,25-dihydroxyvitamin D, and intact FGF23, but there were no significant differences in these values between DMP1cre;Klotho fl/fl mice and DMP1cre;Klotho +/+ mice ( Figure 13 ). Addition of high-phosphate diet after 5/6 nephrectomy induced a more marked increase in intact FGF23 together with significant increases in serum calcium, PTH, and 1,25-dihydroxyvitamin D, but no significant differences were observed between DMP1cre;Klotho fl/fl mice and DMP1cre;Klotho +/+ mice ( Figure 13 ). Histomorphometric analyses performed at 12 weeks of age (7 weeks after 2nd surgery) revealed that bone volume/total volume (BV/TV) was increased in DMP1cre;Klotho fl/fl mice compared to DMP1cre;Klotho +/+ mice after sham surgery (Figure 14) , consistent with data on mice at 5 weeks of age. There were no significant increases in serum PINP as well as bone formation marker by RT-PCR analyses at this point (data not shown). The increased bone volume in DMP1cre;Klotho fl/fl mice remained significant even after 5/6 nephrectomy, but this increase was diminished by 5/6 nephrectomy plus high-phosphate diet (Figure 14 ). We also found that the expression of Klotho in osteocytes was depressed in mice after 5/6 nephrectomy plus high-phosphate diet (Figure 15) , as has been shown in the kidney and parathyroid glands from patients with renal failure. In summary, osteocyte-targeted deletion of Klotho did increase bone formation and bone mass without significant alterations in mineral metabolism. This finding is consistent with recent data suggesting the effect of Klotho to inhibit vascular and skeletal mineralization in cultured cells. Interestingly, the effect of Klotho deletion on bone formation was diminished after 5/6 nephrectomy plus high-phosphate diet, which may be due to overt renal osteodystrophy and depressed Klotho expression in bone cells. Cell Metab. 2010 Jun 9; 11(6):517-3) .
Runx2 is expressed earlier in the differentiation of bone cells and will therefore increase the effect of Klotho loss by affecting a greater percentage of bone. This will enhance the effects we have already seen in other lines and enable us to delve further into physiology of the phenotype. We have recently obtained our first Runx2cre;Klotho fl/fl mutants and are starting to collect tissues and samples for our analyses. We will hopefully complete those studies in this year and will submit the work for publication before the end of the funding.
